SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Johansson Lars Erik) srt2:(2020-2024)"

Sökning: WFRF:(Johansson Lars Erik) > (2020-2024)

  • Resultat 1-10 av 43
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  • Folkersen, Lasse, et al. (författare)
  • Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.
  • 2020
  • Ingår i: Nature metabolism. - : Springer Science and Business Media LLC. - 2522-5812. ; 2:10, s. 1135-1148
  • Tidskriftsartikel (refereegranskat)abstract
    • Circulating proteins are vital in human health and disease and are frequently used as biomarkers for clinical decision-making or as targets for pharmacological intervention. Here, we map and replicate protein quantitative trait loci (pQTL) for 90 cardiovascular proteins in over 30,000 individuals, resulting in 451 pQTLs for 85 proteins. For each protein, we further perform pathway mapping to obtain trans-pQTL gene and regulatory designations. We substantiate these regulatory findings with orthogonal evidence for trans-pQTLs using mouse knockdown experiments (ABCA1 and TRIB1) and clinical trial results (chemokine receptors CCR2 and CCR5), with consistent regulation. Finally, we evaluate known drug targets, and suggest new target candidates or repositioning opportunities using Mendelian randomization. This identifies 11 proteins with causal evidence of involvement in human disease that have not previously been targeted, including EGF, IL-16, PAPPA, SPON1, F3, ADM, CASP-8, CHI3L1, CXCL16, GDF15 and MMP-12. Taken together, these findings demonstrate the utility of large-scale mapping of the genetics of the proteome and provide a resource for future precision studies of circulating proteins in human health.
  •  
3.
  • Bohgard, Mats, et al. (författare)
  • Nu krävs satsning på forskning för ett hållbart arbetsliv
  • 2021
  • Ingår i: Dagens Medicin. - 1104-7488.
  • Tidskriftsartikel (populärvet., debatt m.m.)abstract
    • Debatt: Vi vill att forskningsråden skapar tvärvetenskapliga regionala forskningscentrum för arbetslivsforskning, som är internationellt konkurrenskraftiga och ger nationellt och regionalt kunskapsstöd. Dessa centrum ska ge kunskaper för både befintliga och framtida utmaningar. Stora vinster kan fås om forskning om folkhälsa och yttre miljö samordnas i centrumen. Arbetslivet är grunden för hälsa, välstånd och ett välfungerande samhälle. För att säkra att framtidens arbetsliv bidrar till hälsa och välstånd behövs både kunskap om hur det ska utformas och en uthållig infrastruktur för forskning. Tyvärr saknas detta. Gammal kunskap faller i glömska.
  •  
4.
  • Delsing, Lars-Olof, et al. (författare)
  • Litteraturkrönika 2019
  • 2020
  • Ingår i: Arkiv för nordisk filologi. - 0066-7668. ; 135, s. 167-202
  • Recension (övrigt vetenskapligt/konstnärligt)abstract
    • Anmälningar av div böcker
  •  
5.
  • Delsing, Lars-Olof, et al. (författare)
  • Litteraturkrönika 2020
  • 2021
  • Ingår i: Arkiv för nordisk filologi. - 0066-7668.
  • Recension (övrigt vetenskapligt/konstnärligt)abstract
    • Anmälningar av div. böcker
  •  
6.
  • Delsing, Lars-Olof, et al. (författare)
  • Litteraturkrönikan 2021
  • 2022
  • Ingår i: Arkiv för nordisk filologi. - 0066-7668. ; 137, s. 145-174
  • Recension (övrigt vetenskapligt/konstnärligt)abstract
    • Anmälningar av diverse böcker
  •  
7.
  • Gustafsson, Stefan, et al. (författare)
  • Markers of imminent myocardial infarction
  • 2024
  • Ingår i: Nature Cardiovascular Research. - : Springer Nature. - 2731-0590.
  • Tidskriftsartikel (refereegranskat)abstract
    • Myocardial infarction is a leading cause of death globally but is notoriously difficult to predict. We aimed to identify biomarkers of an imminent first myocardial infarction and design relevant prediction models. Here, we constructed a new case–cohort consortium of 2,018 persons without prior cardiovascular disease from six European cohorts, among whom 420 developed a first myocardial infarction within 6 months after the baseline blood draw. We analyzed 817 proteins and 1,025 metabolites in biobanked blood and 16 clinical variables. Forty-eight proteins, 43 metabolites, age, sex and systolic blood pressure were associated with the risk of an imminent first myocardial infarction. Brain natriuretic peptide was most consistently associated with the risk of imminent myocardial infarction. Using clinically readily available variables, we devised a prediction model for an imminent first myocardial infarction for clinical use in the general population, with good discriminatory performance and potential for motivating primary prevention efforts.
  •  
8.
  • Larsson, Erik, 1983, et al. (författare)
  • The Influence of KCl and HCl on the High-Temperature Oxidation of a Fe-2.25Cr-1Mo Steel at 400 °C
  • 2020
  • Ingår i: Oxidation of Metals. - : Springer Science and Business Media LLC. - 1573-4889 .- 0030-770X. ; 93:1-2, s. 29-52
  • Tidskriftsartikel (refereegranskat)abstract
    • The influence of alkali- and chlorine-containing compounds on the corrosion of superheater alloys has been studied extensively. The current paper instead investigates the corrosive effects of KCl and HCl under conditions relevant to waterwall conditions. A low-alloy (Fe-2.25Cr-1Mo) steel was exposed to KCl(s), 500 vppm HCl(g) and (KCl + HCl) in the presence of 5%O2 and 20% H2O at 400 °C. The results indicate that alloy chlorination by KCl occurs by an electrochemical process, involving cathodic formation of chemisorbed KOH on the scale surface and anodic formation of solid FeCl2 at the bottom of the scale. The process is accompanied by extensive cracking and delamination of the iron oxide scale, resulting in a complex, convoluted scale morphology. Adding 500 vppm HCl to the experimental environment (KCl + HCl) initially greatly accelerated the formation of FeCl2 at the scale/alloy interface. The accelerated alloy chlorination is attributed to HCl reacting with KOH at the scale surface, causing the cathodic process to be depolarized. A rapid slowing down of the rate of chlorination and corrosion in KCl + HCl environment was observed which was attributed to the electronically insulating nature of the FeCl2 layer which forms at the bottom of the scale, disconnecting the anodic and cathodic regions.
  •  
9.
  • Leidermark, Erik, 1981, et al. (författare)
  • Estimating the risk for secondary cancer following targeted alpha therapy with astatine-211 intraperitoneal radioimmunotherapy.
  • 2022
  • Ingår i: Journal of nuclear medicine : official publication, Society of Nuclear Medicine. - : Society of Nuclear Medicine. - 1535-5667. ; 64:1, s. 165-172
  • Tidskriftsartikel (refereegranskat)abstract
    • Intraperitoneal 211At-based targeted alpha therapy (TAT) may hold most promise as an adjuvant therapy following surgery and chemotherapy in epithelial ovarian cancer to eradicate any remaining undetectable disease. This implies it will also be delivered to patients possibly already cured by the primary treatment. An estimate of long-term risks is therefore sought whether to justify the treatment. Methods: Baseline data for risk estimates of alpha-particle irradiation were collected from published studies on excess cancer induction and mortality for subjects exposed to either 224Ra treatments or Thorotrast contrast agent (25% ThO2 colloid, containing 232Th). Organ dosimetry for 224Ra and Thorotrast irradiation were taken from the literature. These organ-specific risks were then applied for our previously reported dosimetry for intraperitoneal (i.p.) 211At-TAT patients. Results: Risk could be estimated for 10 different organ or organ groups. The calculated excess relative risk per Gray (ERR/Gy) could be sorted into two groups. In the lower ERR/Gy group, up to approx. 5, were: Trachea, bronchus and lung 0.52 (CI 95% 0.21-0.82), Stomach 1.4 (CI 95% -5.0-7.9), Lymphoid and hematopoietic system 2.17 (CI 95% 1.7-2.7), Bone and articular cartilage 2.6 (CI 95% 2.0-3.3), Breast 3.45 (CI 95% -10-17) and Colon 4.5 (CI 95% -3.5-13). In the higher ERR/Gy group, ranging from approx. 10 to 15 were: Urinary bladder 10.1 (CI 95% 1.4-23), Liver 14.2 (CI 95% 13-16), Kidney 14.9 (CI 95% 3.9-26) and Lip, oral cavity and pharynx 15.20 (CI 95% 2.73-27.63). Applying a typical candidate patient (female, age 65 years) and correcting for reference population mortality rate, a total estimated excess mortality of an i.p. 211At-mAb treatment amounted to 1.13 per 100 treated. More than half of this excess originated from urinary bladder and kidney, 0.29 and 0.34 respectively. Depending on various adjustments in calculation and assumptions on competing risks excess mortality could range from 0.11 - 1.84 per 100 treated. Conclusion: Published epidemiological data on life-long detriment following alpha-particle irradiation and its dosimetry allowed calculations to estimate the risk for secondary cancer following 211At-based i.p. TAT. Measures to reduce dose to the urinary organs may further decrease the estimated relative low risk for secondary cancer from 211At-mAb based i.p. TAT.
  •  
10.
  • Maksimovic, M., et al. (författare)
  • The Solar Orbiter Radio and Plasma Waves (RPW) instrument
  • 2020
  • Ingår i: Astronomy and Astrophysics. - : EDP SCIENCES S A. - 0004-6361 .- 1432-0746. ; 642
  • Tidskriftsartikel (refereegranskat)abstract
    • The Radio and Plasma Waves (RPW) instrument on the ESA Solar Orbiter mission is described in this paper. This instrument is designed to measure in-situ magnetic and electric fields and waves from the continuous to a few hundreds of kHz. RPW will also observe solar radio emissions up to 16 MHz. The RPW instrument is of primary importance to the Solar Orbiter mission and science requirements since it is essential to answer three of the four mission overarching science objectives. In addition RPW will exchange on-board data with the other in-situ instruments in order to process algorithms for interplanetary shocks and type III langmuir waves detections.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 43
Typ av publikation
tidskriftsartikel (37)
recension (3)
rapport (1)
konferensbidrag (1)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (37)
övrigt vetenskapligt/konstnärligt (4)
populärvet., debatt m.m. (2)
Författare/redaktör
Johansson, Lars-Gunn ... (8)
Svensson, Jan-Erik, ... (7)
Johansson, Lars (4)
Berglund, Jan Erik (4)
Antoni, Gunnar (3)
Agartz, Ingrid (3)
visa fler...
Brouwer, Rachel M (3)
Westlye, Lars T (3)
Andreassen, Ole A (3)
Johansson, Jonas (3)
Andersson, Micael (3)
Peters, Gregory, 197 ... (3)
Eriksson, Olof (3)
Stefansson, Kari (3)
Johansson, Stefan (3)
de Geus, Eco J. C. (3)
Martin, Nicholas G. (3)
Boomsma, Dorret I. (3)
Velikyan, Irina, 196 ... (3)
Haavik, Jan (3)
Tillner, Joachim (3)
Kaufmann, Tobias (3)
van der Meer, Dennis (3)
Djurovic, Srdjan (3)
Cichon, Sven (3)
Hashimoto, Ryota (3)
Hoffmann, Per (3)
Schofield, Peter R (3)
Jacquemont, Sebastie ... (3)
Helander, T. (3)
Nyberg, Lars, 1966- (3)
Le Hellard, Stephani ... (3)
Stefánsson, Hreinn (3)
Halvarsson, Mats, 19 ... (3)
Ames, David (3)
Hottenga, Jouke-Jan (3)
Johansson, Lars-Olof ... (3)
Wagner, Michael (3)
Jahanshad, Neda (3)
Crespo-Facorro, Bene ... (3)
Tordesillas-Gutierre ... (3)
Groenewold, Nynke A (3)
Stein, Dan J (3)
Wittfeld, Katharina (3)
Schork, Andrew J (3)
Edlund, Lars-Erik (3)
Teumer, Alexander (3)
Desrivieres, Sylvane (3)
Schumann, Gunter (3)
Delsing, Lars-Olof (3)
visa färre...
Lärosäte
Lunds universitet (14)
Chalmers tekniska högskola (12)
Uppsala universitet (10)
Karolinska Institutet (8)
Göteborgs universitet (7)
Umeå universitet (7)
visa fler...
Kungliga Tekniska Högskolan (3)
Linköpings universitet (3)
Luleå tekniska universitet (1)
Örebro universitet (1)
RISE (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (37)
Svenska (6)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (17)
Teknik (16)
Naturvetenskap (10)
Samhällsvetenskap (8)
Humaniora (3)
Lantbruksvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy